Influence of Hypertension Management on Survival in Patients With Metastatic Breast Cancer
In patients with mBC, all-cause mortality risk was lower among those treated with antihypertensive polytherapy versus monotherapy, with the greatest risk attenuation seen among Hispanic women. Additional prospective studies are needed to examine comorbidity management strategies that may help patients with mBC extend life, particularly including women of color.
Authors
- Lauren P. Wallner (ORCID: https://orcid.org/0000-0002-1279-8617)
- D Barac
- Ariel Silverman (ORCID: https://orcid.org/0000-0001-7221-3505)
- Reina Haque (ORCID: https://orcid.org/0000-0001-8563-3330)
- Lie Hong Chen (ORCID: https://orcid.org/0000-0003-0989-7144)
- Moira Brady-Rogers
- Zheng Gu
- Tiffany A Hogan
- Amrita Mukherjee
Institutions
- Kaiser Permanente (US)
- Georgetown University (US)
- University of Michigan (US)
- Women Alive (US)
- Michigan Medicine (US)
- Kaiser Permanente West Los Angeles Medical Center (US)
- Alaska Heart and Vascular Institute (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1002/cam4.71642
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00